Statewide legal status
Connecticut lists psilocybin and psilocyn in Schedule I. Ordinary possession remains unlawful outside authorized activity.

CT legal and access quick reference
Reviewed July 22, 2026A concise, source-dated explanation of statewide law, regulated access, and the difference between state and local policy.
Laws and implementation can change quickly. This page is educational information, not legal advice.
Connecticut lists psilocybin and psilocyn in Schedule I. Ordinary possession remains unlawful outside authorized activity.
Connecticut operates a limited Department of Mental Health and Addiction Services pilot in which eligible participants may receive psilocybin-assisted therapy only as part of an FDA-approved research program.
Public Act 26-108 expanded pilot eligibility in 2026. It did not create retail sales, personal-use legality, service centers, or general clinical access.
For Hartford, New Haven and Stamford, this Connecticut page is the appropriate quick-reference starting point because no separate municipal action was retained as a distinct local-policy guide. Local rules can change, so verify current official records.
The statewide explanation above covers Hartford, New Haven and Stamford. A separate page appears below only where a documented municipal action adds material local context.
This review uses Connecticut’s current Schedule I regulation and possession statute plus official records for the psychedelic-assisted therapy pilot. The pilot is research-limited and is not general public access.
Connecticut lists psilocybin and psilocyn in Schedule I. Ordinary possession remains unlawful outside authorized activity. Connecticut operates a limited Department of Mental Health and Addiction Services pilot in which eligible participants may receive psilocybin-assisted therapy only as part of an FDA-approved research program.
Connecticut operates a limited Department of Mental Health and Addiction Services pilot in which eligible participants may receive psilocybin-assisted therapy only as part of an FDA-approved research program.
No. Local enforcement choices do not repeal state law, legalize commercial sales, or create a statewide access program.
The product-site link provides product-format and business-policy information. It does not change the law described on this page or establish legal access in any jurisdiction.